Bai Wenliang, Li Shanqing
Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, P.R. China.
Oncol Lett. 2021 Jan;21(1):74. doi: 10.3892/ol.2020.12335. Epub 2020 Nov 25.
With improvements in detection technology, increasing numbers of patients with non-small cell lung cancer (NSCLC) are being diagnosed at an early stage. In order to treat the illness with minimal invasion and preserve lung function to the greatest possible extent, there has been an increasing tendency towards treating early-stage NSCLC by segmentectomy. However, questions remain regarding whether patients may benefit from this procedure considering the surgical and oncological outcomes. Whether adequate margin distance and lymph node dissection may be achieved is one of the most important issues associated with this procedure. The present study reviews the prognosis of segmentectomy in the treatment of stage IA NSCLC.
随着检测技术的进步，越来越多的非小细胞肺癌（NSCLC）患者在早期被诊断出来。为了以最小的侵袭性治疗疾病并尽可能保留肺功能，通过肺段切除术治疗早期NSCLC的趋势日益增加。然而，考虑到手术和肿瘤学结果，患者是否能从该手术中获益仍存在疑问。能否实现足够的切缘距离和淋巴结清扫是与该手术相关的最重要问题之一。本研究回顾了肺段切除术治疗IA期NSCLC的预后。
